Fig. 2From: The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysisNumber of patients analyzed at each assessment period and reasons for exclusion. aPatients with missing serum phosphate values in the previous quarter who could not be analyzed despite receiving SFOH therapyBack to article page